大家在查：安德鲁·克逊普里米蒂 Oppenheimer&Co 等于沿 Bianko Sikka 内德维凯泽克 and Autumn 一至六

氯吡

网络forchlorfenuron

氯吡

氯吡

forchlorfenuron

常用植物生长调节剂应用指南----中国图书网... ... 15.调节安( DMC) 20.氯吡( forchlorfenuron) 36.核苷酸( nucleotide) ...

1

Conclusion The PPI esomeprazole has no significant influence on inhibition of platelet aggregation by clopidogrel .

结论未发现埃索美拉唑对氯吡格雷的抗血小板聚集作用产生明显影响。

3

The difference was primarily due to a reduction in the rate of stroke with clopidogrel .

两组间差异主要源于使用氯吡格雷减低中风发生率。

7

Objective To explore the application and therapeutic efficacy of Plavix in patients undergoing percutaneous coronary intervention ( PCI ).

目的探讨氯吡格雷在经皮冠状动脉介入治疗（PCI ）中的应用及疗效。

8

Patients undergoing stent-based PCI should be treated with triple therapy consisting of aspirin, clopidogrel, and warfarin .

植入支架的 PCI 患者应该应用阿司匹林、氯吡格雷和华法林三联治疗。

9

Experiment results show that the stability of the clopidogrel bisulfate tablet of the invention is excellent .

实验表明，本发明的硫酸氢氯吡格雷片剂的稳定性优异。

10

Background : Clopidogrel is an anti-platelet agent which causes an increase in bleeding time .

背景：氯吡格雷是一种导致凝血时间延长的抗血小板药物。

11

The rates of adverse cardiovascular events were lowest in patients treated with both clopidogrel and enoxaparin, the investigators report.

并且同时应用氯吡格雷和依诺肝素的患者心血管事件的发生率最低。

12

Recent mechanistic studies, however, suggest that omeprazole may reduce the inhibitory effect of clopidogrel on platelet aggregation.

然而已有机制研究提出奥美拉唑会降低氯吡格雷抗血小板的疗效。

13

14

15

As demonstrated, the combination of aspirin, clopidogrel and oral anticoagulants increase three to five-fold the hemorrhagic risk .

联合使用阿司匹林、氯吡格雷和口服抗凝药使出血的风险增加 3~5 倍。

18

Patients with clopidogrel resistance had high platelet aggregation and were apt to suffer from cardiovascular events .

氯吡格雷抵抗者血小板聚集率高，易发生心血管事件。

20

His group is planning to launch a trial of the drug , which has been approved for use in people for more than a decade , in lupus patients .

氯吡格雷被批准在人类中使用已经有十几年了，他的研究小组计划在狼疮患者中对该药物进行试验。

22

Objective : To assess the PPB rate and outcome and identify risk factors associated with PPB in patients taking clopidogrel.

目的：评估服用氯吡格雷病人 PPB 的发生率，结果以及相关的危险因素。

24

Objective To explore the effect of clopidogrel bisulfate on aspirin resistance (AR ) in patients with ischemic cerebrovascular disease .

目的观察氯吡格雷对缺血性脑血管病患者阿司匹林抵抗（AR ）的影响。

27

Background : Response variability to clopidogrel therapy has been demonstrated .

背景：已有研究显示氯吡格雷治疗反应的变异性。

28

The incidence of clopidogrel resistance was evaluated by the percent reduction of PAGM.

根据 PAGM 降低程度判断氯吡格雷抵抗发生率。

29

Preferred drugs in the order : first choice as clopidogrel, to aspirin second choice, third choice as ticlopidine .

优选药物的次序为：第一选择为氯吡格雷，第二选择为阿司匹林，第三选择为噻氯匹啶。

30

In this article, we reviewed the efficacy and security of high-loading-dose of Clopidogrel in Acute Coronary Syndrome .

现就应用高负荷剂量氯吡格雷治疗急性冠状动脉综合征的有效性和安全性进行综述。

热词推荐

大家在看